API Particle Size Risks During Lab-to-Pilot Scale-Up


Published on 01/06/2026

Addressing API Particle Size Risks During the Transition from Lab to Pilot Scale

Transitioning from laboratory-scale to pilot-scale manufacturing poses numerous challenges, particularly when it comes to achieving consistent API particle size. Variability in particle size can significantly impact downstream processing, product performance, and ultimately, regulatory compliance. This article will guide you through a step-by-step approach to identify, investigate, and mitigate particle size risks during the scale-up process. By following these steps, you will be better equipped to address common issues, improve your manufacturing feasibility, and ensure robust pilot batch development.

After reading this article, you will be able to identify symptoms of particle size issues, implement immediate containment actions, and develop a structured CAPA strategy to prevent future risks associated with API particle size variability.

1. Symptoms/Signals on the Floor or in the Lab

Detecting anomalies early is key for preventing larger issues during the scale-up process. Here are some common symptoms and signals that may indicate risks associated with API particle size during lab-to-pilot scale transitions:

  • Inconsistent API Assays: Fluctuating assay results across batches can
signal particle size issues.
  • Particle Size Distribution (PSD) Variability: Significant shifts in PSD as indicated by laser diffraction or sieve analysis.
  • Increased Filtration Times: Difficulty in filtration processes may indicate undesirable particle sizes.
  • Process Instability: Unusual fluctuations in processing parameters (pressure, temperature) during scale-up trials.
  • Rework or Scrap Rate: Elevated rework or scrap percentage prompts further investigation.
  • 2. Likely Causes

    Particle size variability can emerge from numerous sources. By categorizing these causes, you can better direct your investigation efforts:

    Materials

    • Variability in raw materials (e.g., excipient quality, particle size of APIs).
    • Inconsistent batch-to-batch quality of solvents or reagents.

    Method

    • Inappropriate mixing speeds or times resulting in agglomeration or insufficient dispersion.
    • Inadequate control of crystallization parameters leading to undesired particle size.

    Machine

    • Equipment malfunction or calibration issues affecting operational parameters.
    • Inconsistent performance from mixing or milling equipment.

    Man

    • Operator variability in adhering to SOPs during scale-up.
    • Lack of training on new equipment or processes.

    Measurement

    • Inaccurate measurement techniques for PSD and API concentration.
    • Inadequate sampling procedures that do not represent the entire batch.

    Environment

    • Humidity or temperature fluctuations impacting material storage or processing.
    • Contamination from cross-process interactions in the manufacturing suite.

    3. Immediate Containment Actions (first 60 minutes)

    Taking swift action can minimize the risk of contamination or further defects. Here are immediate containment measures to consider within the first hour:

    1. Isolate Affected Batches: Segregate any batches suspected of non-compliance to maintain control.
    2. Review Batch Records: Check raw data and logs for any irregularities during processing.
    3. Stop Processing: Cease operations on any affected equipment to prevent further contamination.
    4. Compounding Documentation: Document all findings, including timestamps, personnel present, and observed symptoms.
    5. Notify Stakeholders: Communicate with QA and management teams to escalate the issue for immediate review.

    4. Investigation Workflow (data to collect + how to interpret)

    Once immediate containment actions are undertaken, a structured investigation is essential. Here’s how to proceed:

    1. Data Collection: Compile relevant data from batch records, material specifications, and process parameters. This includes:
      • PSD results from both lab and pilot scale.
      • Environmental monitoring data.
      • Equipment maintenance records.
      • Operator training logs.
    2. Visual Analysis: Conduct visual inspections of APIs at different steps to identify inconsistencies.
    3. Statistical Analysis: Use statistical tools to analyze trends across batches and correlate to processing parameters.
    4. Cross-functional Discussions: Involve teams from R&D, Quality Control, and Engineering to gather diverse insights.

    5. Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

    Employ root cause analysis tools to identify underlying issues. Here’s how and when to use them:

    5-Why Analysis

    This is a straightforward approach to drill down into the cause of an issue by asking “Why?” up to five times. It is effective for simple problems.

    Fishbone Diagram

    Utilize this tool for more complex issues with multiple contributing factors. It helps visualize different categories of causes (Materials, Methods, Machines, etc.) and how they might interconnect.

    Fault Tree Analysis

    Use this for highly technical situations where you may need to assess the probability of failures and the relationships between different causes. It’s particularly useful in regulatory environments where thorough documentation is needed.

    6. CAPA Strategy (correction, corrective action, preventive action)

    Implementing an effective CAPA strategy is critical for managing particle size risks:

    Type Actions Responsibility
    Correction Reprocess affected batches with tight control on mixing parameters. Manufacturing Lead
    Corrective Action Conduct retraining sessions for staff on SOP adherence and equipment operation. Training Coordinator
    Preventive Action Implement stricter controls on material inspections to eliminate variability. Quality Assurance Manager

    7. Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    A robust control strategy is paramount for minimizing variability. Here are the components:

    Statistical Process Control (SPC)

    Utilize SPC to monitor critical process parameters. Set control limits and regularly review data trends for early detection of anomalies.

    Sampling Protocols

    Establish rigorous sampling and testing protocols at each production step. Ensure samples are representative of bulk API to eliminate biases.

    Related Reads

    Alarms and Alerts

    Implement real-time monitoring with alarm systems for key processing parameters. This can include filtration pressures, mixing speeds, and temperature control.

    Verification Protocols

    Regularly verify the effectiveness of control measures through periodic reviews and audits of production data.

    8. Validation / Re-qualification / Change Control Impact (when needed)

    The transition from lab to pilot scale may necessitate extensive validation and re-qualification of processes:

    • If adjustments to equipment or processes are made, a full re-validation is often required.
    • Document changes and perform risk assessments to identify potential impacts on product quality.
    • Adhere to [ICH Q7B](https://ich.org/page/quality-guidelines) guidelines for non-sterile APIs to ensure compliance.

    9. Inspection Readiness: What Evidence to Show (records, logs, batch docs, deviations)

    Preparation for regulatory inspection requires robust documentation. Key evidence to maintain includes:

    • Batch Records: Comprehensive records of every batch detailing processes and parameters.
    • Deviation Logs: Document any deviations along with their investigations and CAPAs.
    • Environment Monitoring Records: Compliance with environmental controls and documentation of conditions during processing.
    • Training Records: Proof of operator training on new techniques or equipment updates.

    FAQs

    What are the signs of particle size issues in API manufacturing?

    Signs include inconsistent assay results, variations in PSD, and increased filtration times.

    What immediate actions should be taken if particle size issues are detected?

    Immediate actions include isolating affected batches, reviewing batch records, and stopping processing on affected equipment.

    How do I categorize the causes of particle size variability?

    Causes can be categorized into materials, methods, machines, man, measurement, and environment factors.

    What root cause analysis tool should I choose?

    Use a Fishbone Diagram for complex issues, and 5-Why analysis for simpler problems. Fault Tree Analysis is ideal for assessing probabilities in technical failures.

    What documentation is necessary for regulatory inspections?

    Maintain robust documentation including batch records, deviation logs, and training records to ensure inspection readiness.

    How often should I perform validation for processes?

    Validation should be done whenever there are changes to processes, equipment, or with every new product development.

    What should be included in the CAPA strategy?

    CAPA strategies should include corrections, corrective actions, and preventive actions tailored to the specific causes of variability.

    What is the role of SPC in preventing particle size variability?

    SPC helps in monitoring critical process parameters, enabling early detection of issues, thus preventing variability in particle size.

    What is the importance of training for operators during scale-up?

    Training ensures that operators adhere to SOPs and understand the nuances of new equipment and processes, reducing human errors.

    When is re-validation necessary in the scale-up process?

    Re-validation is necessary whenever there are significant changes to equipment or processes that could impact product quality.

    If you find our Articles useful
    Add us as preferred source on Google
    Pharma Tip:  Sterile Product Lab-to-Pilot Scale Challenges and Controls
    If you find our Articles useful
    Add us as preferred source on Google